Year Established :
2008
Main Competitive Advantages :
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Reputation,Quality Service
Business Type :
Manufacturer
R&D Capacity :
Own Brand
Main Sales Markets :
Central/South America,Eastern Europe,Asia,Middle East,Africa
Product Range :
Recombinant Human Interferon α2b Injection
Recombinant Human Interferon α2b Vaginal Effervescent Tablets
Compound Glycyrrhizin Injection / Capsules / Tablets
Naloxone Hydrochloride Injection
Pirfenidone Tablets
Coblopasvir Hydrochloride Capsule
Sofosbuvir Tablets
Peginterferon α-2 Injection
Recombinant Human Interferon α2b Stock Solution
GCSF & PEG-GCSF